Alzheimer’s Research Snapshot: Drs. Yona Levites and Marshall Goodwin
New study lends insights into factors that could help predict the efficacy of gene therapies using a genetically engineered antibody to target abnormal tau proteins.
New study lends insights into factors that could help predict the efficacy of gene therapies using a genetically engineered antibody to target abnormal tau proteins.
The UF departments of neuroscience and psychiatry and MBI co-sponsored the 10th annual North Central Florida Chapter of the SfN Conference.
Dr. Jeremy McIntyre is featured in our first installment of MBI Rising Stars, highlighting up-and-coming neuroscience researchers at UF.
Dr. Todd Golde is featured in Florida GATOR Magazine's Spring 2019 edition alongside some of UF's top neuroscientists.
Tony Wyss-Coray, Ph.D., a professor of neurology and neurological sciences at Stanford University, will deliver the keynote address for the McKnight Inter-institutional Meeting at 10 a.m. Thursday, April 11 at the Harrell Medical Education Building (Room LS 125). Wyss-Coray will discuss the systemic regulation of brain aging and neurodegeneration.
UF neuroscience students spread to public schools this week and hosted field trips at UF’s McKnight Brain Institute and academic health center.
Alcohol and Drug Addiction: The Gain in the Brain is in the Pain.
A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:
A new study led by Drs. Sara Burke and Abbi Hernandez showed that implementing a ketogenic diet even late in life may be beneficial for improving cognitive outcomes.
Dr. Todd Golde and colleagues published a review in Nature Neuroscience highlighting the usefulness and limitations of using mouse models to study neurodegenerative diseases.